1-7 of 7
Parth Narendran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes

Sky T. H. Ng, Ph.D., Michael J. Price, Ph.D., Naomi Richardson, Ph.D., Maher Nawaf, Ph.D., Alastair Copland, Ph.D., Heather B. Streeter, Ph.D., Parth Narendran, Ph.D., David C. Wraith, Ph.D.
Journal: Diabetes
Diabetes db230996
https://doi.org/10.2337/db23-0996
Published: 21 November 2024
View article titled, Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes
Open the PDF for Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes in another window
Meeting Abstracts

951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study

LALANTHA LEELARATHNA, CHRIS J. SUTTON, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON, PARTH NARENDRAN, KATHARINE BARNARD, VICKY P. TAXIARCHI, MATTHEW BURNS, MAISIE E. CAMM, HOOD THABIT, EMMA G. WILMOT, ON BEHALF OF THE FLASH-UK TRIAL STUDY GROUP
Journal: Diabetes
Diabetes 2023;72(Supplement_1):951-P
https://doi.org/10.2337/db23-951-P
Published: 20 June 2023
View article titled, 951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study
Meeting Abstracts

633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study

KATHARINE BARNARD, VICKY P. TAXIARCHI, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON, PARTH NARENDRAN, CHRIS J. SUTTON, MATTHEW BURNS, HOOD THABIT, EMMA G. WILMOT, LALANTHA LEELARATHNA
Journal: Diabetes
Diabetes 2023;72(Supplement_1):633-P
https://doi.org/10.2337/db23-633-P
Published: 20 June 2023
View article titled, 633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study
Meeting Abstracts

167-OR: Significant Differences in DKA Outcomes across Hospitals Despite Same Guidelines Highlights the Need for Better Implementation Strategies—Results from DEKODE Initiative

PUNITH KEMPEGOWDA, LAKSHMI RENGARAJAN, PARTH NARENDRAN, DEKODE TEAM
Journal: Diabetes
Diabetes 2023;72(Supplement_1):167-OR
https://doi.org/10.2337/db23-167-OR
Published: 20 June 2023
View article titled, 167-OR: Significant Differences in DKA Outcomes across Hospitals Despite Same Guidelines Highlights the Need for Better Implementation Strategies—Results from DEKODE Initiative
Meeting Abstracts

931-P: Supporting Physical Activity in Children with Type 1 Diabetes: A Survey of Health Care Professionals

EMMA COCKCROFT, PARTH NARENDRAN, EVA WOODING, ROBERT C. ANDREWS
Journal: Diabetes
Diabetes 2021;70(Supplement_1):931-P
https://doi.org/10.2337/db21-931-P
Published: 01 June 2021
View article titled, 931-P: Supporting Physical Activity in Children with Type 1 Diabetes: A Survey of Health Care Professionals
Meeting Abstracts

153-OR: Measurement of C-Peptide at Diagnosis Informs Glycemic Control but Not Hypoglycemic Risk in Type 1 Diabetes

ALICE CARR, RICHARD A. ORAM, PARTH NARENDRAN, ROBERT C. ANDREWS
Journal: Diabetes
Diabetes 2021;70(Supplement_1):153-OR
https://doi.org/10.2337/db21-153-OR
Published: 01 June 2021
View article titled, 153-OR: Measurement of C-Peptide at Diagnosis Informs Glycemic Control but Not Hypoglycemic Risk in Type 1 Diabetes
Journal Articles

Alternative Approach to Immunomodulation for Type 1 Diabetes: Antigen-Specific Immunotherapy In Utero

Parth Narendran
Journal: Diabetes
Diabetes 2015;64(10):3347–3349
https://doi.org/10.2337/db15-0825
Published: 16 September 2015
View article titled, Alternative Approach to Immunomodulation for Type 1 Diabetes: Antigen-Specific Immunotherapy In Utero
Open the PDF for Alternative Approach to Immunomodulation for Type 1 Diabetes: Antigen-Specific Immunotherapy In Utero in another window